POZEN Inc. was a pharmaceutical firm focused on developing unique therapeutic solutions for underserved medical conditions. Its pipeline primarily included advanced treatments for migraine and explored other areas within pain management. The company pursued a model of advancing drug candidates through clinical stages for out-licensing, ultimately merging to form Aralez Pharmaceuticals plc in 2016.